Self monitoring of blood glucose in type 2 diabetes
- PMID: 18420661
- PMCID: PMC2394584
- DOI: 10.1136/bmj.39538.469421.80
Self monitoring of blood glucose in type 2 diabetes
Abstract
May not be clinically beneficial or cost effective and may reduce quality of life
Conflict of interest statement
Competing interests: None declared.
Comment on
-
Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial.BMJ. 2008 May 24;336(7654):1174-7. doi: 10.1136/bmj.39534.571644.BE. Epub 2008 Apr 17. BMJ. 2008. PMID: 18420662 Free PMC article. Clinical Trial.
References
-
- O’Kane MJ, Bunting B, Copeland M, Coates VE; on behalf of the ESMON Study Group. Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial. BMJ 2008; doi: 10.1136/bmj.39534.571644.BE - DOI - PMC - PubMed
-
- Simon J, Gray A, Clarke P, Wade A, Neil A, Farmer A; on behalf of the Diabetes Glycaemic Education Monitoring Trial Group. Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial. BMJ 2008; doi: 10.1136/bmj.39526.674873.BE - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical